Literature DB >> 15736024

High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India.

Deepak Almeida1, Camilla Rodrigues, Tester F Ashavaid, Ajit Lalvani, Zarir F Udwadia, Ajita Mehta.   

Abstract

We report a high frequency (35%) of the Beijing genotype among multidrug-resistant isolates recovered in and around Mumbai, India. Further restriction fragment-length polymorphism typing showed that these strains were closely related. We also report a high frequency of the Delhi genotype (31% of isolates). Our data indicate considerable ongoing transmission of multidrug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in Mumbai.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736024     DOI: 10.1086/427940

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Mutation detection and accurate diagnosis of extensively drug-resistant tuberculosis: report from a tertiary care center in India.

Authors:  Kanchan Ajbani; Camilla Rodrigues; Shubhada Shenai; Ajita Mehta
Journal:  J Clin Microbiol       Date:  2011-02-02       Impact factor: 5.948

2.  Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.

Authors:  Ben J Marais; Charmaine K Mlambo; Nalin Rastogi; Thierry Zozio; Adriano G Duse; Thomas C Victor; Else Marais; Robin M Warren
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

3.  A genome-wide analysis of multidrug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis Beijing genotype.

Authors:  Wei Wu; Huajun Zheng; Lu Zhang; Zilu Wen; Shulin Zhang; Hao Pei; Guohua Yu; Yongqiang Zhu; Zhenling Cui; Zhongyi Hu; Honghai Wang; Yao Li
Journal:  Mol Genet Genomics       Date:  2013-06-26       Impact factor: 3.291

4.  Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.

Authors:  Tomasz Jagielski; Ewa Augustynowicz-Kopec; Thierry Zozio; Nalin Rastogi; Zofia Zwolska
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Characterization of mutations conferring extensive drug resistance to Mycobacterium tuberculosis isolates in Pakistan.

Authors:  Asho Ali; Rumina Hasan; Kauser Jabeen; Nusrat Jabeen; Ejaz Qadeer; Zahra Hasan
Journal:  Antimicrob Agents Chemother       Date:  2011-09-12       Impact factor: 5.191

6.  Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.

Authors:  Susan L Baldwin; Valerie A Reese; Po-Wei D Huang; Elyse A Beebe; Brendan K Podell; Steven G Reed; Rhea N Coler
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

7.  Mycobacterium tuberculosis transmission is not related to household genotype in a setting of high endemicity.

Authors:  B J Marais; A C Hesseling; H S Schaaf; R P Gie; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

8.  Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei.

Authors:  Horng-Yunn Dou; Fan-Chen Tseng; Chih-Wei Lin; Jia-Ru Chang; Jun-Ren Sun; Wen-Shing Tsai; Shi-Yi Lee; Ih-Jen Su; Jang-Jih Lu
Journal:  BMC Infect Dis       Date:  2008-12-22       Impact factor: 3.090

9.  Mycobacterium tuberculosis genotype and case notification rates, rural Vietnam, 2003-2006.

Authors:  Tran N Buu; Mai N T Huyen; Nguyen N T Lan; Hoang T Quy; Nguyen V Hen; Matteo Zignol; Martien W Borgdorff; Dick van Soolingen; Frank G J Cobelens
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

10.  In-depth molecular characterization of Mycobacterium tuberculosis from New Delhi--predominance of drug resistant isolates of the 'modern' (TbD1) type.

Authors:  Ruth Stavrum; Vithal Prasad Myneedu; Virendra K Arora; Niyaz Ahmed; Harleen M S Grewal
Journal:  PLoS One       Date:  2009-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.